Marshall Wace’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Marshall Wace's ANGO Position: Q1 2026 in Review
Marshall Wace increased its AngioDynamics (ANGO) stake by 71% in Q1 2026, buying an estimated $2.18M and bringing the position to 485,504 shares worth $5.52M. The position accounts for 0.01% of the portfolio, ranked #1257.
Marshall Wace first reported a position in ANGO in Q2 2019 and has held it in 17 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Marshall Wace held 485,504 shares of AngioDynamics worth $5.52M as of Q1 2026.
- Marshall Wace bought 200,816 AngioDynamics shares in Q1 2026, an estimated $2.18M.
- AngioDynamics made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1257 holding.
- Marshall Wace first reported a position in AngioDynamics in Q2 2019 and has held it in 17 quarters since.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.